PJ Lee, CM Hung, AJ Yang, CY Hou, HW Chou… - Gut …, 2024 - Taylor & Francis
4 天前 - … have been proposed to regulate the immunesystem and are considered one of the strategies that can be used to improve the response to immunotherapy. Citation3 For …
25 天前 - … This study presents extendedImmunityAgent-BasedModel (IABM) … immunesystem response, and the work done by antibodies forming a microscopic dynamic within the model…
31 天前 - … aims to better characterize molecular changes in the intestines of CeD patients in response to … Furthermore, a gluten challenge activated immuneresponse genes and induced …
M Iulini, G Russo, E Crispino, A Paini, S Fragki… - Computational and …, 2024 - Elsevier
33 天前 - … , the agent-basedmodel (ABM) Universal ImmuneSystem … and in particular it was extended and applied to a case study on … We simulated the immunesystemresponse after a …
X Si, G Ji, S Ma, L Liu, Z Zhu, Y Zhang, Z Tang… - Science China …, 2024 - Springer
51 天前 - … sustained stimulation of the immunesystem at the site of the lesion, and the generation of … Trinity immuneenhancing nanoparticles for boosting antitumor immuneresponses of …
HG Roider, S Hoff, SY Tseng, S Berndt… - Clinical and …, 2024 - Springer
53 天前 - … While systemic depletion of Tregs can enhance antitumor immunity, it also triggers undesirable autoimmuneresponses. Therefore, there is a need for therapeutic agents that …
Y Dong, X Zhang, Y Wang, T Xu - 2024 - researchsquare.com
56 天前 - … immune landscape and immunotherapeutic response of LUSC. Lastly, we identified potential therapeutic agents … suggesting that they may have better survival outcomes. CMLS …
J Czapla, A Drzyzga, J Ciepła, S Matuszczak… - Cancer Immunology …, 2024 - Springer
60 天前 - … It involves activating the host's own immunesystem to … results in a better anti-tumor response in poorly immunogenic … models we have noted stimulation of innate immune …
X Qian, H Yang, Z Ye, B Gao, Z Qian, Y Ding, Z Mao… - ACS …, 2024 - ACS Publications
61 天前 - … agents. This study investigated the potential of celecoxib (CXB) to enhance PTX-… primed a T cell-dependent immuneresponse, leading to enhanced tumor rejection in a …